Rajasinghe Hiranya A, Tzilinis Argyrios, Keller Theresa, Schafer Jeff, Urrea Sandra
Vascular Surgery and Endovascular Intervention, Anchor Health Centers, Naples, FL 34102, USA.
Vasc Endovascular Surg. 2006;40(6):460-6. doi: 10.1177/1538574406294366.
There is increasing interest in using endovascular methods instead of surgical reconstruction to treat popliteal artery aneurysms. Exclusive use of the Viabahn stent-graft, a nitinol stent covered with expanded polytetrafluoroethylene, was assessed in the treatment of patients who presented with popliteal artery aneurysms in the absence of acute limb ischemia. Technical success, endoleaks, graft patency, freedom from amputation, and aneurysm sac flow and size changes were assessed by duplex ultrasound. From June 2004 to March 2006, 16 men (mean age, 76 years; range, 65-83) underwent endovascular exclusion of 23 popliteal artery aneurysms (mean diameter, 2.5 cm; range, 1.3-6.7 cm). Nine lesions had partial thrombus on preprocedural duplex imaging. Nineteen of the 23 limbs treated had at least 2-vessel tibial artery runoff. Procedures were performed under local anesthesia using ipsilateral percutaneous antegrade arterial access. All patients received 75 mg/day of clopidogrel afterward. Follow-up assessments included direct clinical examinations and duplex ultrasonography performed 1, 3, 6, and 12 months after the procedure. Primary patency and amputation-free survival were calculated using Kaplan-Meier analysis. Complete aneurysm exclusion (technical success) was achieved in all cases. During the mean follow-up of 7 months (range, 1-21 months), 22 of 23 treated limbs remained asymptomatic. One stent-graft thrombosis occurred 6 months after the procedure and was successfully treated with percutaneous mechanical thrombectomy, balloon angioplasty of a stent-graft stenosis, and insertion of an uncovered nitinol stent. No popliteal artery aneurysm sac size enlargements or endoleaks were detected. At 12 months, the treated limb mean ankle-brachial index was 1.0 (range, 0.82-1.31) and the primary and secondary patency rates were 93% and 100%, respectively. Early results with Viabahn endovascular stent-graft exclusion of asymptomatic popliteal artery aneurysms are promising. Patient selection for endovascular repair depends on suitable popliteal artery anatomy, extent of aneurysmal degeneration, and quality of tibial arterial runoff.
使用血管内方法而非手术重建来治疗腘动脉瘤的兴趣日益增加。在治疗无急性肢体缺血的腘动脉瘤患者时,评估了单纯使用Viabahn覆膜支架(一种覆盖有膨体聚四氟乙烯的镍钛诺支架)的效果。通过双功超声评估技术成功率、内漏、移植物通畅情况、免于截肢以及动脉瘤囊血流和大小变化。2004年6月至2006年3月,16名男性(平均年龄76岁;范围65 - 83岁)接受了23个腘动脉瘤的血管内隔绝术(平均直径2.5 cm;范围1.3 - 6.7 cm)。9个病变在术前双功成像时有部分血栓形成。23条接受治疗的肢体中有19条至少有双支胫动脉血流。手术在局部麻醉下使用同侧经皮顺行动脉入路进行。所有患者术后均接受每日75 mg的氯吡格雷治疗。随访评估包括术后1、3、6和12个月进行的直接临床检查和双功超声检查。使用Kaplan - Meier分析计算主要通畅率和免于截肢生存率。所有病例均实现了完全动脉瘤隔绝(技术成功)。在平均7个月(范围1 - 21个月)的随访期间,23条接受治疗的肢体中有22条无症状。术后6个月发生1例支架移植物血栓形成,经皮机械血栓切除术、支架移植物狭窄球囊血管成形术以及置入裸镍钛诺支架成功治疗。未检测到腘动脉瘤囊大小增大或内漏。12个月时,治疗肢体的平均踝肱指数为1.0(范围0.82 - 1.31),主要和次要通畅率分别为93%和100%。Viabahn血管内支架移植物隔绝无症状腘动脉瘤的早期结果很有前景。血管内修复的患者选择取决于合适的腘动脉解剖结构、动脉瘤退变程度以及胫动脉血流质量。